Switch to:
More From Other Websites
OncoGenex Regains Rights to Custirsen from Teva Apr 27 2015
OncoGenex Regains Rights to Custirsen from Teva Apr 27 2015
OncoGenex Regains Rights to Custirsen from Teva Apr 27 2015
Straight-Talking Teva Boss May Find Mylan Toughest Target Apr 27 2015
Humana (HUM), Gilead Sciences (GILD), McKesson Corporation (MCK) Among Sivik Global’s Top... Apr 24 2015
Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds Apr 24 2015
Teva-Active Biotech Start Phase II on MS Drug - Analyst Blog Apr 24 2015
Mylan makes official bid for Perrigo in generic drug contest Apr 24 2015
Mylan makes official bid for Perrigo in generic drug contest Apr 24 2015
Raised Bid in Three-Way Generic Drug Takeover Battle Apr 24 2015
Techs surge on earnings, boosts Nasdaq, S&P 500 to record close Apr 24 2015
Deutsche Bank Boosts Mylan's Price Target On This Scenario Apr 24 2015
Mylan/Perrigo, a more likely combination: Pro Apr 24 2015
Will a Mylan 'Stichting' Become a Sticking Point for a Teva Deal? Apr 24 2015
Teva, Mylan and Perrigo: Which Combination is Most Likely? Apr 24 2015
Generic drugmaker Mylan goes hostile in bid for Perrigo Apr 24 2015
Perrigo rejects formal Mylan takeover offer Apr 24 2015
Perrigo Plans to Reject Mylan Takeover Offer Apr 24 2015
Mylan tries to fend off Teva with bigger bid for Perrigo Apr 24 2015
Mylan's Formal Offer For Perrigo Will Heat Up Pharma Dealmaking Apr 24 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK